Home » acute » Recent Articles:

Stentys Self-expanding Stent Receives CE Marking To Treat Acute Coronary Syndrome (ACS)

March 8, 2010 Health News No Comments

Medical device pioneer Stentys announced that it has received CE Marking for its self-expanding and disconnectable stent to treat acute coronary syndrome (ACS). The self-expanding feature of the Stentys platform, unrivaled in the stent industry, is designed to ensure optimal apposition of a stent in the critical initial hours and days after an acute myocardial infarction (AMI) procedure, by being continuously applied to the vessel’s internal surface even during thrombus and vessel spasm relief-thereby avoiding malapposition, a significant concern to cardiologists…

Go to Source… Continue reading

World-Renowned Radiologist Speaks Out On The Over-Use, Radiation Exposure, And Expense Of CTs Ordered For Women With Acute Pelvic Conditions

March 3, 2010 Health News No Comments

In a bold, eye-opening editorial in the March 2010 issue of the Journal of Ultrasound in Medicine, Harvard Professor, Beryl Benacerraf, MD, urges the medical community to use ultrasound instead of Computed Tomography (CT) as the first-line imaging test for better diagnosis capability in the evaluation of acute female pelvic and lower abdominal conditions…

Go to Source… Continue reading

Surveys Reveal High Frequency Of Prodromal Symptoms Prior To Acute Hereditary Angioedema Attacks

March 2, 2010 Health News No Comments

Patients with hereditary angioedema (HAE) experience prodromal or early warning symptoms before nearly three-quarters of their HAE attacks, according to survey findings presented at the 2010 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting. According to researchers, this high frequency suggests that prodromal symptoms may reliably indicate when to initiate treatment to help prevent an acute HAE attack. To identify the prodromal symptoms patients experienced before an HAE attack, two separate surveys were conducted…

Go to Source… Continue reading

Hospitalization For Acute Care Or Critical Illness Associated With Greater Likelihood Of Subsequent Cognitive Decline For Older Adults

March 2, 2010 Health News No Comments

Older patients hospitalized for acute care or a critical illness are more likely to experience cognitive decline compared to older adults who are not hospitalized, according to a study in the February 24 issue of JAMA. A large proportion of patients who are hospitalized for acute care or care of a critical illness are older adults. Some studies have suggested that many survivors of critical illness experience long-term cognitive impairment, but these studies did not measure cognitive function before a critical illness, according to background information in the article. William J…

Go to Source… Continue reading

Acute Study Demonstrates Safety Of Vertos Medical’s Mild(R) Procedure; Findings Appear In Pain Physician Journal

February 26, 2010 Health News No Comments

Medical device company Vertos Medical Inc. has reported that an observational study on mild*, published in the January/February 2010 issue of the peer-reviewed journal Pain Physician, has demonstrated the acute safety of the procedure in the treatment of lumbar spinal stenosis (LSS).1 The study, conducted by leading pain physicians Timothy Deer, M.D. (The Center for Pain Relief, Charleston, West Va.) and Leonardo Kapural, M.D., Ph.D. (Cleveland Clinic, Cleveland, Ohio), found no reports of patient complications related to the mild devices or technique…

Go to Source… Continue reading

Sunesis Poised For Phase 3 Trial Of Voreloxin In Acute Myeloid Leukemia After Completing Formal End-of-Phase 2 Meetings With FDA

February 26, 2010 Health News No Comments

Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) announced that it has completed formal End-of-Phase 2 meetings with the U.S. Food and Drug Administration (FDA) related to its lead compound, voreloxin, in acute myeloid leukemia (AML). Sunesis has received feedback and guidance from the FDA in response to proposed plans for further development of voreloxin in the treatment of AML. Based on the development clarity achieved as a result of these meetings, Sunesis intends to proceed with its plan to conduct a randomized, double-blind, placebo-controlled, pivotal Phase 3 trial…

Go to Source… Continue reading

What Is Altitude Sickness (acute Mountain Sickness)? What Causes Altitude Sickness?

February 20, 2010 Health News No Comments

Altitude sickness, also called acute mountain sickness (AMS), altitude illness, hypobaropathy, Acosta disease, puna, or soroche is a disorder caused by being at high altitude where air pressure is low without prior acclimatization (the process of gradual exposure). If it does occur, it will do so at altitudes above 8,000 feet (2,500 meters) – 8000 meters is a common height for many ski resorts. More severe symptoms generally occur at above 3,600 meters (about 12,000 feet). Acute mountain sickness can progress to high altitude pulmonary edema (HAPE) or high altitude cerebral edema (HACE)…

Go to Source… Continue reading

Karolinska Development: EMEA Recommends Orphan Drug Designation For Acute Myeloid Leukemia Treatment

February 19, 2010 Health News No Comments

The European Medicines Agency (EMEA) recommends orphan drug status for Aprea’s treatment of acute myeloid leukemia (AML). The treatment is currently undergoing a Phase I clinical study and a final decision from the European Commission regarding status is expected in a few weeks. Aprea is part of the Karolinska Development portfolio. “Aprea is developing a new class of anticancer drugs for the treatment of acute myelogenous leukemia, the most common acute leukemia affecting adults which is currently lacking efficient treatment…

Go to Source… Continue reading

UC Study Supports Alternative Anti-Seizure Medication Following Acute Brain Injury

February 19, 2010 Health News No Comments

A study by researchers at the University of Cincinnati Neuroscience Institute (UCNI) at University Hospital supports the use of an alternative medication to prevent seizures in patients who have suffered a life-threatening traumatic brain injury or bleeding stroke. This randomized study supports earlier indications that the anti-seizure medication levetiracetam, marketed as Keppra, was as effective at preventing seizures as the traditional medication, phenytoin, marketed as Dilantin, while producing fewer negative side effects…

Go to Source… Continue reading

Lessons from acute pancreatitis-induced thrombotic thrombocytopenic purpura.

Authors: Thachil J
Acute pancreatitis is an inflammatory disease characterized by local tissue injury which can trigger a systemic inflammatory response. There is increasing evidence that endothelial dysfunction is one of the critical pathophysiologic manifestations in patients with severe form of acute pancreatitis. In keeping with this, there have been recent reports of a haematological disorder, thrombotic thrombocytopenic purpura (TTP), as being precipitated by acute pancreatitis. However, the patients who develop TTP, secondary to acute pancreatitis, do not always have the characteristic low levels of VonWillebrand multimer cleaving enzyme, ADAMTS-13 suggesting the involvement of other pathophysiological factors. On the contrary… Continue reading

ADS:

Featured Content:

In Massachusetts, the Pros and Cons of New Imaging Technology

March 11, 2010

Fast-growing spending on imaging tests in Massachusetts gives a closeup view to the many-sided question of whether improved technology is really worth the extra cost.
The facts, as laid out by the Boston Globe this morning: Spending on MRIs, mammograms, and other imaging tests for privately insured Massachusetts residents jumped 20%, or $214 million, between 2006 and 2008, according to consultants hired by the state. Doctors ordering more tests was one reason for the added spending.
Digital mammography was another prime driver as some insurers pay more for these breast-screening tests and hospitals have invested upward of $400,000 for such new machines… Continue reading

In Massachusetts, the Pros and Cons of New Imaging Technology

March 11, 2010

Fast-growing spending on imaging tests in Massachusetts gives a closeup view to the many-sided question of whether improved technology is really worth the extra cost.
The facts, as laid out by the Boston Globe this morning: Spending on MRIs, mammograms, and other imaging tests for privately insured Massachusetts residents jumped 20%, or $214 million, between 2006 and 2008, according to consultants hired by the state. Doctors ordering more tests was one reason for the added spending.
Digital mammography was another prime driver as some insurers pay more for these breast-screening tests and hospitals have invested upward of $400,000 for such new machines… Continue reading

Years of smoking associated with lower Parkinson’s risk, not number of cigarettes per day

March 11, 2010

Researchers have new insight into the relationship between Parkinson’s disease and smoking. Several studies have shown that smokers have a lower risk of developing Parkinson’s disease. A new study published in the March 10, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology, shows that smoking for a greater number of years may reduce the risk of the disease, but smoking a larger number of cigarettes per day may not reduce the risk.

“These results could guide the development of studies on various tobacco components with animal models to help understand the relationship between smoking and… Continue reading

NC State Research Tackles Childhood Obesity

March 11, 2010

Getting children involved in finding ways to become more physically active can not only make them more aware of local recreational opportunities, but can even help increase their own physical activity.

That’s the result of a study examining the role of seven national parks in contributing to the health of today’s youth. The study was conducted by researchers from a variety of disciplines at North Carolina State University and other U.S. universities and funded by the National Park Service.

The researchers developed pilot programs aimed at increasing the awareness of health benefits from participating in recreational activities at national parks and increasing… Continue reading

Smoking years key factor in lower Parkinson’s risk

March 11, 2010

Several studies have shown that smokers have a lower risk of developing Parkinson’s disease. A new study shows that it’s how many years of smoking a person has under their belt—rather than how much they smoke every day—that matters.

“Smoking is bad for you and no one should advocate smoking just for prevention of Parkinson’s,” Dr. Honglei Chen of the National Institute of Environmental Health Sciences in Research Triangle Park, North Carolina, one of the study’s authors, emphasized in comments to Reuters Health. But the findings could help researchers who are trying to figure out the underlying cause of the disease… Continue reading

Study says fat is the sixth “taste”

March 11, 2010

People sensitive to the taste of fat tend to eat less of it and are less likely to be overweight, according to Australian research that found human tongues can detect fatty tastes.

Researchers at Deakin University, working with colleagues at the University of Adelaide among others, found that fat was the sixth taste people can identify in addition to the five others – sweet, sour, salty, bitter and protein-rich.

In a statement, Deakin researcher Russell Keast said the findings build on previous research in the United States that used animal models to discover the taste for fat. Go to Source… Continue reading

Thyroid Hormone Analogue for Treating High Cholesterol

March 11, 2010

An experimental thyroid drug reduces cholesterol without the troublesome side effects experienced by some people on statins, according to a study published today in The New England Journal of Medicine.  An international team of investigators at Johns Hopkins Medical Institutions, the Karolinska University Hospital and Institute, and The Feinstein Institute for Medical Research tested a substance called Eprotirome in patients with high cholesterol.

Following 189 people with high cholesterol over a three-month period, they observed that it lowered cholesterol levels without the classic thyroid risks to the heart and bone, The study was supported by Karo Bio in Sweden, a company… Continue reading

School Lunches: The Good, The Bad, and The Ugly

March 11, 2010

Ah, school cafeteria lunches. …
They might have pleasant memories for you, of peeling back the silver foil and taking a whiff of that sweet-smelling warm hamburger bun (or maybe a whiff of those “Li’l Smokies” – remember those?).
But school lunches – and their degradation into unhealthy fat- and sugar-powerhouses for our kids – were part of the topic First Lady Michelle Obama addressed in her keynote speech to the National PTA at the annual PTA conference in Washington, D.C., yesterday.
Improving school lunches is one element of a four-pronged approach the First Lady is launching in her new “Let’s Move!” campaign… Continue reading

Recent Comments:

  • SurfinGuy508: My Girl friend just broke up with me and I have uploaded every nude PIC I have of her to the net. Just go to http://www.gf4free.com/members/surferdude...
  • symptoms of dementia: What's the difference between dementia and Alzheimers? what is the difference? I think my father may be suffering one of these? does anyone know the w...
  • rani: good blog thank 4 the info...
  • JourneyHome: McCarran-Ferguson was originally designed to empower both the federal government and the individual states so that they could act to prevent insurance...
  • Hydro Closet: Hi, I thought I would say you have a wonderful site and rich content. I bookmarked your site and have it in my reader now...looking forward to future ...